Back to search results

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Israel
RecruitingPHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Multiple Myeloma, Refractory to Standard Treatment · Multiple Myeloma, Relapsed · Light Chain Amyloidosis

Locations
  • Hadassah MO, Jerusalem, Israel
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)